Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases

The heparan sulfate (HS) mimic/heparanase inhibitor roneparstat (SST0001) shows antitumor activity in preclinical sarcoma models. We hypothesized that this 100% N-acetylated and glycol-split heparin could interfere with the functions of several receptor tyrosine kinases (RTK) coexpressed in sarcomas...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Cassinelli, Giuliana, Favini, Enrica, Dal Bo, Laura, Tortoreto, Monica, De Maglie, Marcella, Dagrada, Gianpaolo, Pilotti, Silvana, Zunino, Franco, Zaffaroni, Nadia, Lanzi, Cinzia
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216983/
https://ncbi.nlm.nih.gov/pubmed/27374103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10292
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items